[A new approach to innovating selective anxiolytics: pharmacological profile of a novel 5-HT1A agonist (tandospirone)].
Sasa, M
[A new approach to innovating selective anxiolytics: pharmacological profile of a novel 5-HT1A agonist (tandospirone)]. [electronic resource] - Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology Apr 1997 - 53-9 p. digital
Publication Type: English Abstract; Journal Article; Review
1340-2544
Aggression--drug effects
Animals
Anti-Anxiety Agents--metabolism
Antidepressive Agents--pharmacology
Autonomic Nervous System Diseases--drug therapy
Benzodiazepines--adverse effects
Haplorhini
Humans
Ion Channel Gating--drug effects
Isoindoles
Piperazines--metabolism
Potassium Channels--metabolism
Pyrimidines--metabolism
Rats
Receptors, Serotonin--metabolism
Serotonin Receptor Agonists--metabolism
[A new approach to innovating selective anxiolytics: pharmacological profile of a novel 5-HT1A agonist (tandospirone)]. [electronic resource] - Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology Apr 1997 - 53-9 p. digital
Publication Type: English Abstract; Journal Article; Review
1340-2544
Aggression--drug effects
Animals
Anti-Anxiety Agents--metabolism
Antidepressive Agents--pharmacology
Autonomic Nervous System Diseases--drug therapy
Benzodiazepines--adverse effects
Haplorhini
Humans
Ion Channel Gating--drug effects
Isoindoles
Piperazines--metabolism
Potassium Channels--metabolism
Pyrimidines--metabolism
Rats
Receptors, Serotonin--metabolism
Serotonin Receptor Agonists--metabolism